Live feed
·
NEWSReleasevia Quantisnow
eFFECTOR Therapeutics Inc. logo

eFFECTOR Therapeutics To Wind Down Operations And Seek Potential Strategic Alternatives, Expects To Delist From Nasdaq

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EFTR (eFFECTOR Therapeutics Inc.) and more on Quantisnow.